+7 (499) 350-59-54

Tag: Stocks

Healthcare: Highlights For Two Growth Stocks

Two companies seem poised for continued strong upside appreciation. Overall descretionary healthcare spend still increasing.

More Beat Up Blue Chips

Recently we highlighted several best-of-breed large capitalization companies that have materially under performed this year. Another three companies are examined below. These are not speculative names. They are not richly valued technology or consumer discretionary stocks either. They have wide defensive moats and should be beneficiary of strong cyclical and secular uptrend. But they under performed enough during 2021 with …

More Beat Up Blue Chips Read More »

To access this post, you must purchase Subscription Plan – AVC Pro.

Beaten Down Blue Chips

Several high quality companies now sell for discounted prices after the strong sell since Thanksgiving. The main US indexes maintain relatively high sales and earnings multiples historically. This masks the damage done to most small stocks and even some blue chip names that most astute investors continually monitor for buying opportunities. We highlight three stocks …

Beaten Down Blue Chips Read More »

To access this post, you must purchase Subscription Plan – AVC Pro.

Value vs Growth

value vs growth
As the market starts a bounce from oversold conditions, lets look at where money is flowing.
To access this post, you must purchase Subscription Plan – AVC Pro.

US Stock Market Update

Entering a bullish period after a fake out breakdown overreaction after the FOMC last week. What to watch this summer and what is setting up for a run now.

Stock Trade: Month End Catalyst

Diabetes Catalyst
With this stock out of favor yet showing some stable base building, investors are ignoring major catalyst occurring before month end.
To access this post, you must purchase Subscription Plan – AVC Pro.

Stock Idea: FDA Softens

Biogen's new Alzheimer's, drug approval has investors pondering whether this is enough of a change in mindset to reshape opinions about gene editing companies. Bets are being placed in the options market.
To access this post, you must purchase Subscription Plan – AVC Pro.

Stock Idea: Latin American Payments

Latin American Bank
We see option activity picking up in our favorite Latin American payment service company. Morgan Stanley analysts expect stronger than expected growth. The chart looks interesting for the stock to run again.
To access this post, you must purchase Subscription Plan – AVC Pro.

Stock Idea: A Tesla Rival

EV rerating
Tesla, the best innovator with first mover advantage in EV space, gets all the attention. It has a lofty multiple while other auto makers were shunned. Recently, new products signal a change.
To access this post, you must purchase Subscription Plan – AVC Pro.

Stock Idea: Urban Air Travel

Urban Air
JPMorgan makes the case for an early stage growth opportunity within an established company: Urban Air Travel.
To access this post, you must purchase Subscription Plan – AVC Pro.

For Whom

Our Expertise

Our Solutions

This information is not an individual investment recommendation, and the financial instruments or transactions mentioned in it may not correspond to your investment profile and investment goals (expectations). It is your task to determine whether a financial instrument or transaction matches your interests, investment objectives, investment horizon and acceptable risk level. AVC Adisvory, Inc. and its affiliates are not liable for possible losses in case of making transactions or investing in the financial instruments mentioned in this information, and do not recommend using this information as the only source of information when making an investment decision.

Youtube
Scroll to Top